Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study
Background: Cystatin C (Cys-C) is recognized as one of the most reliable renal function parameters in the general population, although it might be biased by thyroid status. Herein, we tested Cys-C and conventional renal parameters in a cohort of hypothyroid patients treated with Levothyroxine. Metho...
Main Authors: | Marta Greco, Daniela Patrizia Foti, Antonio Aversa, Giorgio Fuiano, Antonio Brunetti, Mariadelina Simeoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/9/2958 |
Similar Items
-
Korelasi antara Modification of Diet in Renal Disease (MDRD) dan Cystatin C Serum pada Usia 40–70 Tahun
by: Jason Jus, et al.
Published: (2016-09-01) -
Estimated GFR Accuracy When Cystatin C– and Creatinine-Based Estimates Are Discrepant in Older AdultsPlain-Language Summary
by: O. Alison Potok, et al.
Published: (2023-05-01) -
Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study
by: Jennifer S. Lees, et al.
Published: (2021-08-01) -
Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
by: Anders O. Larsson, et al.
Published: (2022-10-01) -
Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
by: Enver Aydilek, et al.
Published: (2022-09-01)